G. Osaka

Pharmacokinetics, tissue distribution, and expression efficiency of plasmid [33P]DNA following intravenous administration of DNA/cationic lipid complexes in mice: use of a novel radionuclide approach.

P. Godowski, T. Gadek, G. Osaka, 1996, Journal of pharmaceutical sciences.

Molecular and biological properties of an interleukin-1 receptor immunoadhesin.

S. Marsters, R. Pitti, A. Ashkenazi, 1994, Molecular immunology.

Pharmacokinetics and interspecies scaling of recombinant human factor VIII.

G. Osaka, J. Mordenti, G. Meng, 1996, Toxicology and applied pharmacology.

Development of tricalcium phosphate/amylopectin paste combined with recombinant human transforming growth factor beta 1 as a bone defect filler.

G Osaka, G. Osaka, L. Deguzman, 1997, Journal of biomedical materials research.

Development of a humanized disulfide-stabilized anti-p185HER2 Fv-beta-lactamase fusion protein for activation of a cephalosporin doxorubicin prodrug.

L. Presta, P. Carter, W. L. Wong, 1995, Cancer research.

Engineering linear F(ab')2 fragments for efficient production in Escherichia coli and enhanced antiproliferative activity.

P. Carter, J. Ridgway, W. L. Wong, 1995, Protein Engineering.